...
首页> 外文期刊>Pain research & management: the journal of the Canadian Pain Society = journal de la socie?te? canadienne pour le traitement de la douleur >Xm2 Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance
【24h】

Xm2 Scores for Estimating Total Exposure to Multimodal Strategies Identified by Pharmacists for Managing Pain: Validity Testing and Clinical Relevance

机译:Xm2分数,用于评估由药剂师确定的用于管理疼痛的多模式策略的总暴露量:有效性测试和临床相关性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective. To assess the validity of an exposure score obtained from the Xm2 tool for all pharmacological and nonpharmacological strategies used by individuals to manage chronic pain. Methods. Using data from individuals with chronic pain, eXposure multimodal (Xm2) scores were calculated by assigning one point for every 100?mg of morphine equivalent used (opioid medications); 25% of the maximum recommended exposure used (nonopioid medications); and any use of another strategy then summed. Content, criterion, construct, and convergent validity were assessed. Results. The sample of 149 individuals used a mean of 12.6 (SD = 4.6) strategies to manage pain and had a mean Xm2 score of 16.8 (SD = 9.1). Content validity was established by demonstrating that the pain management strategies identified were also reported in the literature. Criterion validity was established by the positive association of exposure scores with the following: interference with work (odds ratio (OR) = 2.23, 95% confidence interval (CI) = 1.14–4.36), daily activities (OR = 2.10, CI = 1.07–4.13), relationships (OR = 1.98, CI = 1.01–3.88), and leisure activities (OR = 2.31, CI = 1.18–4.50); workdays missed (OR = 5.10, CI = 1.92–13.58); emergency department visits (OR = 3.40, CI = 1.17–9.91); hospitalizations (OR = 4.18, CI = 0.86–20.37); and by a negative association with satisfaction (OR = 0.40, CI = 0.18–0.88). Construct validity was established by the positive association of exposure with baseline pain intensity () and odds of experiencing an adverse event (OR = 2.31, CI = 1.18–4.52). Convergent validity was established through correlations of pain intensity from the Xm2 score and existing quantitative analgesic questionnaire (QAQ) score. Discussion. Xm2 scores represent a valid estimate of total exposure to multimodal strategies used and provide clinically relevant information for deciding what strategies to use at what level.
机译:目的。评估从Xm2工具获得的暴露评分对个人用于管理慢性疼痛的所有药理和非药理策略的有效性。方法。使用来自慢性疼痛个体的数据,通过每100?mg吗啡当量(阿片类药物)分配一个点来计算eXposure多模态(Xm2)分数;推荐使用的最大推荐暴露量的25%(非阿片类药物);然后总结使用其他策略。内容,标准,结构和收敛效度进行了评估。结果。 149个人的样本采用平均12.6(SD = 4.6)的策略来控制疼痛,平均Xm2评分为16.8(SD = 9.1)。通过证明在文献中也报告了确定的疼痛管理策略来确定内容的有效性。通过暴露分数与以下各项的正相关关系来建立标准效度:干扰工作(优势比(OR)= 2.23,95%置信区间(CI)= 1.14–4.36),日常活动(OR = 2.10,CI = 1.07) –4.13),人际关系(OR = 1.98,CI = 1.01-3.88)和休闲活动(OR = 2.31,CI = 1.18–4.50);错过的工作日(OR = 5.10,CI = 1.92–13.58);急诊就诊(OR = 3.40,CI = 1.17-9.91);住院(OR = 4.18,CI = 0.86–20.37);并与满意度呈负相关(OR = 0.40,CI = 0.18–0.88)。通过暴露与基线疼痛强度()和经历不良事件的几率之间的正相关关系来确定构建体的有效性(OR = 2.31,CI = 1.18–4.52)。通过Xm2评分与现有定量镇痛问卷(QAQ)评分之间的疼痛强度之间的相关性来建立收敛效度。讨论。 Xm2分数代表对所使用的多式联运策略的总暴露量的有效估计,并提供临床相关信息,以决定在哪个级别使用哪种策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号